Retatrutide 10mg Vial

Sold out
Retatrutide 10mg Vial
$150.00

Overview
Retatrutide (LY3437943) is a cutting-edge investigational peptide classified as a triple hormone receptor agonist, targeting GLP-1, GIP, and glucagon receptors. This multi-pathway mechanism makes it a promising candidate for research into obesity, type 2 diabetes, and metabolic syndrome. 

Key Features

  • Formulation: Lyophilized powder
  • Concentration: 10mg per vial
  • Purity: ≥99%, third-party tested
  • Storage: Store at -4°F (lyophilized); once reconstituted, refrigerate at 36–46°F and use within 30 days 
  • CAS Number: 2381089-83-2
  • Molecular Formula: C227H354N48O69
  • Molecular Weight: 4860 g/mol 

Mechanism of Action
Retatrutide activates three key receptors:

  • GLP-1: Enhances insulin secretion and reduces appetite
  • GIP: Supports insulin sensitivity and energy balance
  • Glucagon: Promotes fat metabolism and energy expenditure 

This synergistic activity has shown promise in delaying gastric emptying, reducing body weight, and improving glycemic control in early-phase clinical trials. 

Research Applications

  • Obesity and weight management
  • Glucose regulation in type 2 diabetes
  • Metabolic syndrome studies
  • Energy expenditure and hormonal balance 

Packaging 

  • Supplied in sterile, unbranded vials for wholesale distribution

Compliance Notice:

  • For research use only. All chemical compounds have risk. Please read the available research and understand the associated risks before handleing. If you are uncertain of the neccessary handling methods, please consult a qualified professional. Misuse of this product may result in adverse reactions. Keep away from children. This product is not approved by the FDA.